Showing results (1-10 of 391) with videos related to
Sort By:
Pageof 40
Cancer Treatment Reviews|April 16, 2026
Integrin beta-6: Its emerging role as a therapeutic target in solid tumorsRachel E Sanborn, Solange Peters, David BarbieCurrent Treatment Options in Oncology|February 20, 2009
Cisplatin versus carboplatin in NSCLC: is there one "best" answer?Rachel E SanbornClinical Advances in Hematology & Oncology : H&O|September 17, 2005
Gastrointestinal stromal tumors and the evolution of targeted therapyRachel E Sanborn, Charles D BlankeExpert Opinion on Drug Safety|March 1, 2006
The safety of bevacizumabRachel E Sanborn, Alan B SandlerExpert Review of Clinical Pharmacology|January 16, 2014
Erlotinib: applications in therapy and current status of researchRachel E Sanborn, Angela M DaviesDermatologic Clinics|November 21, 2007
Cutaneous reactions to chemotherapy: commonly seen, less described, little understoodRachel E Sanborn, David A SauerThoracic Surgery Clinics|December 18, 2008
Adjuvant therapy for non-small cell lung cancer with mediastinal nodal involvementRachel E Sanborn, Brian E LallyCancer Metastasis Reviews|May 16, 2015
Present standards and future perspectives in the treatment of metastatic non-small cell lung cancerStefan Zimmermann, Solange PetersCancer Cell|May 16, 2018
Genomic Features of Response to Combination Immunotherapy in Lung CancerMartin Früh, Solange PetersCurrent Opinion in Oncology|January 4, 2013
Targeting receptor activator of nuclear factor-kappa B as a new therapy for bone metastasis in non-small cell lung cancerSolange Peters, Etienne MeylanPageof 40